We came across a bullish thesis on CRISPR Therapeutics AG (CRSP) on wallstreetbets Subreddit Page by MADD-Scientis. In this article, we will summarize the bulls’ thesis on CRSP. CRISPR Therapeutics AG ...
One of the stocks we analyzed in Thursday's Daily Market Commentary webinar was CRISPR Therapeutics (CRSP), which has gone bananas in 2018. CRSP closed in 2017 at $23.48. It has since gone on to reach ...
Gene editing has emerged as a significant trend in the biopharma investment landscape, contributing to transformative treatment possibilities through DNA modification. CRISPR Therapeutics (CRSP) is a ...
CRISPR Therapeutics CRSP and Vertex Pharmaceuticals Inc. VRTX announced that the FDA has approved Casgevy (exagamglogene autotemcel [exa-cel]) for the treatment of sickle cell disease (SCD) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results